Free Shipping On Orders Over $200 Within Canada!
MDMA therapy for PTSD (MDMA-AT) is an experimental treatment approach that combines a limited number of supervised MDMA dosing sessions with a structured course of psychotherapy, including preparation and integration sessions. The idea is that MDMA’s effects (often described as increasing openness, connection, and reducing fear responses) may help some people engage more effectively with trauma processing during therapy.
Post-traumatic stress disorder (PTSD) is a mental health condition that can develop after someone experiences or witnesses a traumatic event that threatens life, safety, or physical integrity — such as serious accidents, violence, abuse, natural disasters, war, or sexual assault.
Not everyone who goes through trauma gets PTSD, but for those who do, symptoms must last more than one month and cause significant distress or problems in daily life for a diagnosis.
PTSD symptoms typically fall into four categories:
PTSD can happen at any age and is often accompanied by other mental health issues like depression or anxiety.
In Canada, large national surveys show that a significant portion of adults have experienced traumatic events and many report PTSD symptoms:
• About 64% of Canadian adults report experiencing at least one potentially traumatic event in their lifetime.
• Approximately 7.7% of adults report having received a professional PTSD diagnosis at some point in their lives, and 6.1% currently have a diagnosis.
• When using a screening tool for symptoms (not necessarily a clinical diagnosis), 8.5% of adults show moderate to severe PTSD symptoms.
Differences by group:
• Women screen positive at higher rates (about 9.9%) than men (about 7.0%).
• Younger adults (ages 18–24) show higher symptom rates (~13.3%) than older adults (e.g., ~3.0% for those aged 65+).
In the United States, PTSD affects a notable portion of the population, with important differences by gender and age:
• National estimates indicate that about 3.5–4% of U.S. adults have PTSD in a given year.
• Lifetime prevalence — the percentage who will experience PTSD at some point — is around 6–7% of U.S. adults.
Gender differences:
• Women are more likely to experience PTSD than men. U.S. data show females around 5.2% past-year prevalence compared with 1.8% for males, and lifetime rates are higher for women.
Adolescents:
• Around 8% of U.S. adolescents (ages 13–18) may experience PTSD at some point.
A key recent result is the confirmatory Phase 3 randomized, placebo-controlled trial (MAPP2) published in Nature Medicine (Sept 2023). In this study, MDMA-AT produced a larger improvement in clinician-rated PTSD severity (CAPS-5) than placebo with therapy. By study end, 71.2% of participants in MDMA-AT no longer met PTSD diagnostic criteria (vs 47.6% in placebo+therapy);
Traditional, evidence-based PTSD care most often involves trauma-focused psychotherapies (the “gold standard”), and sometimes medications such as SSRIs; however, many patients still have significant symptoms, and dropout can be a challenge. The Nature Medicine Phase 3 paper notes that despite gold-standard trauma-focused therapies, many individuals have persistent symptoms, and that even with FDA-approved SSRIs (sertraline, paroxetine), a substantial minority do not respond.
MDMA-AT differs mainly in how therapy is delivered: it pairs psychotherapy with a few intensive, supervised MDMA sessions plus structured preparation/integration. MDMA-assisted psychotherapy shows promise even in some treatment-resistant PTSD populations, while emphasizing the need to weigh benefits and risks carefully.
Right now, access to MDMA-assisted therapy (MDMA-AT) for PTSD is mostly limited to research pathways because it is not approved for general clinical use either in the United States or Canada. In the U.S., the Department of Veterans Affairs notes that MDMA-AT can be studied in clinical trials, and Veterans interested in this treatment can look for approved trials (including within VA settings) as a legal route to participation. In Canada, Canada’s Health Canada Special Access Program (SAP) allows health-care practitioners to request authorized use of MDMA for individual patients with serious conditions (like treatment-resistant PTSD) on a case-by-case basis, subject to approval and strict oversight.
At Shroom Garden, we are committed to providing a safe option to those who are interested in exploring MDMA therapy online in Canada. We offer a variety of products with MDMA including MDMA molly pills, and MDMA crystal rock. We are offering a special deal for Valentine’s Day for those who are interested in exploring MDMA with their loved ones.
We are committed to promoting the safe and responsible use of our products, which is why we require strict age verification before any purchase is completed. This process ensures that only adults of legal age can access our offerings, in compliance with all relevant laws and regulations. By maintaining these standards, we aim to protect younger individuals from potential harm while fostering a safe environment for informed adult consumers.
Every product we offer undergoes rigorous third-party laboratory testing to verify purity, potency, and dosage accuracy. These tests confirm that each batch is free from harmful contaminants, ensuring that customers receive only the highest-quality products. We make these results available to our consumers as part of our dedication to full transparency and trust.
If you are interested in beginning to explore your MDMA therapy journey with Shroom Garden or exploring MDMA therapy in Canada, our experienced and professional customer service team is here if you wish to buy MDMA in Canada. Please feel free to reach out to our experienced and professional customer service team should have you have any questions.
Disclaimer: Due to the potential legality of MDMA, we cannot and do not endorse or support the use of this drug where it is illegal. However, harm reduction is a crucial aspect of safety, and therefore, this guide is being provided to ensure individuals can make informed decisions and minimize risks when using MDMA. It is important to verify the legality of the substance in the area before consuming it. Additionally, always remember to prioritize safety, and seek medical attention if necessary.
What are you looking for?
